Spotlight: Prof. Eric Rubin’s recent interviews and media appearances
At the Department of Immunology and Infectious Diseases (IID), we’re tackling the toughest global health threats—from TB and malaria to cancer and COVID-19. However, recent federal funding cuts threaten the future of this work by limiting support for scientific inquiry and innovation. As part of the IID community, we remain committed to collaborating across the U.S. and around the world to protect and promote health for all.
Dr. Eric Rubin, Editor-in-Chief of the New England Journal of Medicine (NEJM), has been quoted recently in a number of media outlets.
Dr. Rubin is a Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, and an Associate Physician specializing in infectious diseases at Brigham and Women’s Hospital. In addition to his editorial leadership at NEJM, Dr. Rubin has served on multiple scientific advisory boards for infectious diseases and previously held editorial positions at journals including PLoS Pathogens, Tuberculosis, and mBio.
In recent months, as medical journals and their editors have faced increased public and media scrutiny, Dr. Rubin has been engaged in a number of important discussions regarding the role of scientific publishing, research integrity, and transparency in public health.
This page will be regularly updated to showcase his ongoing contributions to these crucial conversations.
Recent media mentions
- The New York Times (April 25, 2025):
NEJM Prosecutor Letter
Dr. Rubin addresses questions regarding a recent letter from a prosecutor about research integrity at NEJM, emphasizing the journal’s commitment to rigorous ethical standards and transparency in scientific publishing.
Read the article
- NPR Shots (May 2, 2025):
Medical Journals Respond to Government Inquiries
Dr. Rubin discusses actions taken in response to recent federal inquiries, highlighting the ongoing challenges faced by scientific publishers in maintaining public trust.
Read the article
- STAT News (May 15, 2025):
Science Under Scrutiny
Featuring commentary from Dr. Rubin on the growing challenges faced by researchers and journals working in an era of heightened scrutiny and misinformation.
Read the article
- Reuters (May 22, 2025):
COVID-19 Vaccine Policy and the JN.1 Variant
Dr. Rubin contributes his expertise to public discussions on recommended COVID-19 vaccine updates for upcoming immunization campaigns.
Read the article
- Washington Post (July 21,2025)
Advocating for independent Journals
Drs. Rubin and Bibbins-Domingo address the crucial role of medical journals in advancing science while combating misinformation and political interference.
Read the article
